AdvisorShares Psychedelics ETF (PSIL)
NYSEARCA: PSIL · Real-Time Price · USD
19.57
-0.06 (-0.31%)
At close: Apr 28, 2026, 4:00 PM EDT
19.57
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
-0.31% (1D)
| Assets | $31.47M |
| Expense Ratio | 1.00% |
| PE Ratio | n/a |
| Shares Out | 1.57M |
| Dividend (ttm) | $1.72 |
| Dividend Yield | 8.77% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Ratio | n/a |
| 1-Year Return | +66.08% |
| Volume | 39,613 |
| Open | 19.60 |
| Previous Close | 19.63 |
| Day's Range | 19.34 - 19.86 |
| 52-Week Low | 11.10 |
| 52-Week High | 22.49 |
| Beta | 0.90 |
| Holdings | 32 |
| Inception Date | Sep 15, 2021 |
About PSIL
Fund Home PageThe AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is issued by AdvisorShares.
Asset Class Equity
Category Miscellaneous Sector
Stock Exchange NYSEARCA
Ticker Symbol PSIL
ETF Provider AdvisorShares
Top 10 Holdings
68.26% of assets| Name | Symbol | Weight |
|---|---|---|
| AtaiBeckley Inc. | ATAI | 11.08% |
| COMPASS Pathways plc | CMPS | 9.97% |
| Relmada Therapeutics, Inc. | RLMD | 8.68% |
| Definium Therapeutics, Inc. | DFTX | 8.66% |
| GH Research PLC | GHRS | 5.58% |
| NRx Pharmaceuticals, Inc. | NRXP | 5.46% |
| Bright Minds Biosciences Inc. | DRUG | 5.08% |
| Cybin Inc. | HELP | 4.63% |
| Neuronetics, Inc. | STIM | 4.56% |
| Alto Neuroscience, Inc. | ANRO | 4.56% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $1.6839 | Dec 29, 2025 |
| Sep 22, 2025 | $0.0201 | Sep 29, 2025 |
| Jun 23, 2025 | $0.01191 | Jun 27, 2025 |
| Mar 21, 2025 | $0.16343 | Mar 28, 2025 |
| Dec 23, 2024 | $0.0548 | Dec 30, 2024 |
| Sep 23, 2024 | $0.1087 | Sep 30, 2024 |
News
AdvisorShares Applauds Executive Order Accelerating Access to Psychedelic Therapies
Portfolio manager of the AdvisorShares Psychedelics ETF (PSIL) calls executive action a pivotal moment for psychedelic medicine BETHESDA, Md., April 20, 2026 /PRNewswire/ -- AdvisorShares, a leading s...
8 days ago - PRNewsWire
EXCLUSIVE: Investing In The Unique Growth Market Of Psychedelics - AdvisorShares Psychedelics ETF (ARCA:PSIL)
The global psychedelics market of drugs such as psilocybin, ketamine and LSD is booming and there are plenty of ways to get involved in the space.
3 years ago - Benzinga